PALI Exercise Disclosure
Finley John David · SEC Form 4 · Filed Oct 7, 2026
Exercise
Calculated transaction value
$0
Finley John David CEO CFO
PALI
Palisade Bio, Inc.
PALI
Transaction date
Oct 6, 2026
Public filing date
Oct 7, 2026
Filing lag
Filed 1 day later
PALI daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 3,059,800 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-046201
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$2.1M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Palisade Bio, Inc. PALI | Exercise | Oct 6, 2026 | $0 |
| Palisade Bio, Inc. PALI Current | Exercise | Oct 6, 2026 | $0 |
| Palisade Bio, Inc. PALI | Exercise | Oct 6, 2026 | Not reported |
| Palisade Bio, Inc. PALI | Disposition | Oct 6, 2026 | $2.1M |